Clin2
NCT06909188Possibly a fitRecruiting

Helicobacter infection in bile duct cancer patients

Biliary Tract Cancer

Part of Cancer, Digestive system clinical trials.

This study looks for links between Helicobacter bacteria and cancers of the bile ducts and gallbladder. It compares patients with bile duct cancer, people having gallbladder surgery for non-cancer reasons, and healthy liver donors.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
250 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with bile duct or gallbladder cancer and had surgery to remove it.
  • You are having your gallbladder removed for a non-cancer condition (like gallstones).
  • You are a healthy liver donor with no gallbladder problems.
  • You are having your gallbladder removed because you have a condition that raises your risk of cancer (like certain polyps or chronic inflammation).
  • You have NOT taken treatment to get rid of H. pylori in the last three months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04935853Recruiting
Study of markers that predict bile duct cancer treatment response

This study looks at lab markers (including genetic tests) to predict how people with bile duct cancer respond to treatment. Your answers and samples may help doctors personalize care for bile duct cancer in the future.

Amiens
NCT06389500Not yet recruiting· Phase 2
HAIC plus immunotherapy and targeted therapy before surgery for bile duct cancer

This trial tests combining two drugs (adebrelimab and lenvatinib) with a liver-directed chemotherapy infusion (HAIC) to shrink locally advanced bile duct or gallbladder cancers enough to allow surgery. It is for people who haven't had prior treatment for their biliary cancer and whose cancer has not spread far.

NCT06877637Recruiting
Tracking bile duct and liver cancer during treatment

This study tracks how bile duct and liver cancers change during treatment, to help doctors find the best therapies for patients. It is for people who are newly diagnosed or starting a new treatment.

Kristianstad
NCT07206355Recruiting
Studying bile duct and liver lesions for new cancer tests

This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.

Nottingham
NCT07152496Not yet recruiting
Gut and bile bacteria in bile duct widening study

This study looks at how bacteria in your gut and bile duct might affect bile duct widening. By comparing tissue from people with this condition to healthy donor tissue, researchers hope to find new ways to understand and treat it.

Beijing, Beijing Municipality
NCT07292454Not yet recruiting
H. pylori and inflammatory bowel disease study

This study looks at whether people with inflammatory bowel disease (IBD) also have an infection called H. pylori in their stomach. The goal is to learn how common this infection is in IBD patients so doctors can better understand and treat both conditions.

Pointe-à-Pitre, CHU de La Guadeloupe

Hear when a new Biliary Tract Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.